Navigation Links
NxStage® Names Michael Miller, Jr. President, International
Date:4/27/2011

LAWRENCE, Mass., April 27, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Michael Miller, Jr., former Senior Vice President and General Manager of the Cardiac Care Business at Philips Healthcare, has joined the NxStage senior management team in the newly-created position of President, International.

Miller will be responsible for advancing the Company's international growth plans in the European Union (EU), the Middle East, and Asia-Pacific. "I believe NxStage has a tremendous opportunity to expand patient access to its life-changing products across the globe," said Miller. "This is a remarkable company that I believe has the potential to truly transform renal care on an even broader scale.  I am excited to join NxStage and to bring my experience in international medical device sales and business development to its important mission."

During ten years at Philips, Miller held leadership roles in marketing and general management for a variety of global businesses.  In his most recent role as Senior Vice President and General Manager of the Philips Cardiac Care Business he led worldwide expansion efforts for four medical device businesses across new and emerging markets. Prior to Philips, Miller was Director and Vice President of U.S. Sales for Advanced Sterilization Products, a division of Johnson & Johnson Medical, Inc., as well as Director of International and New Business Development- Worldwide.  He also held various positions with Hewlett Packard Medical Products Group that included responsibilities for domestic and international product marketing in several product areas.  Miller holds an MBA from Harvard Graduate School of Business Administration and a BA in economics from Yale University.

"Mike's strong track record in global sales over three dec
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. NxStage® to Report First Quarter Fiscal 2011 Financial Results
2. New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period
3. In Celebration of the 31st Annual Dialysis Conference, NxStage® Announces Over 5,000 Patients Using the System One™ for Home Hemodialysis
4. NxStage® Reports Fourth Quarter and Full-Year 2010 Financial Results; Revenue Growth Exceeds Company Guidance
5. NxStage® to Report Fourth Quarter and Full Year 2010 Financial Results
6. NxStage® Appoints Nancy J. Ham to Its Board of Directors and Announces Resignation of Board Member Jonathan T. Silverstein
7. First NxStage® Home Hemodialysis Patients Celebrate Seven-Year Anniversary
8. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
9. Cetero Research Names 25-Year Industry Veteran James Dixon to Head Quality and Compliance
10. BridgePoint Medical Names Industry Veteran as Chief Executive Officer
11. Survey Sampling International Names Chris DeAngelis to Head New SSI Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , BERLIN and ... Arthroscopy Devices Market to 2018 ... Invasive Procedures to Drive Future Growth" looks at the ... six arthroscopy device market segments: arthroscopes, arthroscopy shavers, arthroscopy ... systems, and arthroscopy visualization systems. The report provides comprehensive ...
(Date:5/20/2013)... 2013  Rhythm announced today the presentation of results ... of gastroparesis symptoms among diabetic patients in the U.S. ... among patients with both type 1 and type 2 ... with the more common type 2 disease. ... Associate Professor of Medicine at Harvard Medical School and ...
(Date:5/20/2013)... May 20, 2013  AbbVie (NYSE: ... Phase 3 clinical study called SONAR (Study Of ... of the investigational compound atrasentan - when added to ... in patients with stage 2 to 4 chronic ... is a large, multinational, double-blind, placebo-controlled clinical study ...
Breaking Medicine Technology:Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 3Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6
... Inc. (Nasdaq: MAPP ) today announced that the ... Stifel Nicolaus Healthcare Conference Thursday, September 8, at ... Sciences Conference Wednesday, September 21, at 9:30 a.m. ET in ... will be available on the Investor Relations section of MAP ...
... THOUSAND OAKS, Calif., Sept. 6, 2011 Amgen (NASDAQ: ... on Thursday, Sept. 8, 2011, at The New York Palace ... Time. Arvind Sood, vice president of Investor Relations at Amgen, ... from the Events Calendar on Amgen,s website, www.amgen.com , ...
Cached Medicine Technology:
(Date:5/20/2013)... New York, NY (PRWEB) May 20, 2013 ... to protecting the rights of victims injured by defective ... South Dakota man who alleges that use of the ... The suit was filed on April 30, 2013, ... of Louisiana (Case No. 6:13-cv-0888), where it is one ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Mirena ... in the multidistrict litigation recently established in U.S. District ... reports. According to court records, the litigation’s first ... time appointments to Plaintiff’s leadership positions were discussed. ... in the Southern District of New York, all of ...
(Date:5/20/2013)... Salt Lake Community College’s Know Greater Heroes program ... winners for 2013. As part of the award, the ... is a leadership training program that involves SLCC athletes who ... eat right, be active, and avoid drugs and alcohol. , ... program each year, and visit more than 30 schools each ...
(Date:5/20/2013)... The judge overseeing pretrial proceedings in ... specifically for female lawyers to be included in a ... Group LLP acknowledges the judge’s request, noting that its ... providing information on Mirena side effects and how to ... the addition of some female lawyers to the committee. ...
(Date:5/20/2013)... 2013 While Huntington,s disease (HD) is currently ... disease-modifying therapies in development may slow or minimize ... depends upon the identification of reliable and sensitive ... these biomarkers may eventually be used as outcome ... helpful to monitor changes during the time prior ...
Breaking Medicine News(10 mins):Health News:Taking Actos for Two Years Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP on Behalf of South Dakota Man 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 3Health News:SLCC Know Greater Heroes Program Named to Select 25 2Health News:SLCC Know Greater Heroes Program Named to Select 25 3Health News:Mirena IUD Lawsuit Update: Judge Calls for More Input from Female Lawyers, Notes Rottenstein Law Group LLP 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 3
... Cleaners Proven to Protect and Even Improve Health, ... homes is,increasingly contaminated and polluted, and now studies have ... not only allergy and asthma,symptoms but also a variety ... clots., Studies are emerging that prove poor indoor ...
... the type diagnosed in Sen. Edward Kennedy , , MONDAY, ... is showing promise against the same general type of ... reporting. , The vaccine, when given with chemotherapy, more ... tumors. Kennedy was diagnosed last month with a malignant ...
... The discovery of new genetic mutations involved in inflammatory ... these common conditions, two scientists told the annual conference ... 2 June). , Dr.Alexandra ... Netherlands, and Dr. Eleonora Festen, from the University of ...
... ST. PETERSBURG, Fla., June 2 The Advanced,Wound Management ... announced,today that its negative pressure wound therapy (NPWT) products ... areas included in the,first phase of the competitive bidding ... (CMS) in the U.S. The program, which is,scheduled to ...
... family of CCRCs with expansion into Alabama;,Community to ... June 2 ACTS Retirement-Life,Communities, a premier not-for-profit ... its acquisition of Carlton Cove, a,continuing care retirement ... renamed Magnolia Trace and become the 19th ACTS,continuing ...
... the body,s own tissues and organs, wreaking havoc and ... of these diseases are so obscure, no effective treatment ... Weizmann Institute scientists have developed a method that in ... diseases effectively without necessarily knowing their exact cause. Their ...
Cached Medicine News:Health News:Studies Find Poor Indoor Air Quality Can Lead to Major Health Problems 2Health News:Studies Find Poor Indoor Air Quality Can Lead to Major Health Problems 3Health News:Vaccine May Boost Survival of Brain Cancer Patients 2Health News:Vaccine May Boost Survival of Brain Cancer Patients 3Health News:Discovery of new family of genetic mutations involved in inflammatory intestinal disease 2Health News:Discovery of new family of genetic mutations involved in inflammatory intestinal disease 3Health News:Smith & Nephew Negative Pressure Wound Therapy Products To Be Available To Patients Through the Medicare Part B Competitive Bidding Process 2Health News:Smith & Nephew Negative Pressure Wound Therapy Products To Be Available To Patients Through the Medicare Part B Competitive Bidding Process 3Health News:Smith & Nephew Negative Pressure Wound Therapy Products To Be Available To Patients Through the Medicare Part B Competitive Bidding Process 4Health News:Smith & Nephew Negative Pressure Wound Therapy Products To Be Available To Patients Through the Medicare Part B Competitive Bidding Process 5Health News:ACTS Retirement-Life Communities Completes Carlton Cove Acquisition 2Health News:Weizmann Institute scientists develop a new approach to treating autoimmune disease 2
...
Designed to minimize emblolic debris in SVGs and carotids...
... the ability of interventional cardiologists and ... disease, and provides non-interventional cardiologists with ... treatment of patients who have become ... provides a noninvasive, atraumatic treatment for ...
... petite titanium model comes with ... lumen) and is our smallest ... offer larger lumen equivalency while ... lumen offset-tip catheters are available ...
Medicine Products: